LAV

LAV is a biomedical venture capital firm specializing in investments across the healthcare sector, including biopharmaceuticals, medical devices, diagnostics, and healthcare services. With offices in Shanghai, Hong Kong, and Palo Alto, the firm manages committed capital exceeding USD 2.33 billion and has invested in over 80 portfolio companies worldwide. LAV's team comprises professionals with substantial biomedical domain expertise and extensive investment experience in China.

The firm's investment strategy is characterized by a focus on exceptional entrepreneurs and high-quality science. LAV is highly selective, supporting entrepreneurs with a unique combination of ambition, experience, leadership, and integrity. The firm emphasizes long-term thinking, aiming to build sustainable companies that catalyze global medical innovations and meet the increasing demand for better healthcare. LAV's portfolio spans various stages, from seed to pre-IPO, reflecting its commitment to supporting companies at different growth phases.

LAV's track record includes significant investments in the biomedical and healthcare industry, with a portfolio covering all major sectors such as biopharmaceuticals, medical devices, diagnostics, and healthcare services. The firm's approach combines deep local expertise in China with a strong global perspective, positioning it uniquely to support portfolio companies and investors worldwide. LAV's vision is to become the trusted partner for exceptional entrepreneurs seeking smart capital, building great companies that develop breakthrough products to treat diseases and improve human health.